Canngea - Martin Bryden & Dr. Nial Wheate
Artikel konnten nicht hinzugefügt werden
Der Titel konnte nicht zum Warenkorb hinzugefügt werden.
Der Titel konnte nicht zum Merkzettel hinzugefügt werden.
„Von Wunschzettel entfernen“ fehlgeschlagen.
„Podcast folgen“ fehlgeschlagen
„Podcast nicht mehr folgen“ fehlgeschlagen
Canngea - Martin Bryden & Dr. Nial Wheate
-
Gesprochen von:
-
Von:
Über diesen Titel
Martin Bryden and Dr. Nial Wheate join me from Canngea. We had a discussion about their business and what they are currently working on in the cannabis industry. We spoke on topics like the current state of the medical, nutraceutical, and recreational industries. Dr Nial Wheate broke down clinical trials and the bioavailability of cannabis.
To let you know Canngea is an Australian company that operates as a B2B Contract Manufacturing Organisation. They focus on Eu-GMP standards (Good Management Practices) and SOP’s (Standard Operating Procedures). Canngea can deliver consistent high-quality products at competitive rates.
They were established in Australia in September 2017. Canngea offers services to other companies in the medicinal cannabis industry to supply white label and private label solutions to produce products for wholesale in the domestic and international markets.
